Covid pill makers accused of selling drug to US at 40 times what it costs to make despite govt funding


coronavirus covid 3 worthy ministries

(Worthy News) – The company producing an experimental antiviral pill for Covid-19 treatment is accused of selling the drug to the US at 40 times the cost of its production, found a report.

Molnupiravir, manufactured by pharmaceutical company Merck, has entered into a contract with the US government to supply 1.7 million courses at a price of $700 per course. However, an analysis of drug pricing by Harvard School of Public Health and King’s College Hospital in London found that it takes about $17.74 to produce a five-day course.

The pill, hailed as a breakthrough in the treatment of coronavirus, was originally developed to treat influenza using government funds. The antiviral drug could halve the chances of dying or being hospitalised for those most at risk of contracting severe Covid-19. [ Source: UK Independent (Read More…) ]

We're being CENSORED ... HELP get the WORD OUT! SHARE!!!

Related News

Latest Worthy News

Wave of Violence Against ICE Sparks Federal Crackdown: Homan Say ‘This Stops Now’
Trump Strikes Trade Deal With Indonesia, Averting Tariff Clash and Opening U.S. Access to Key Resources
Supreme Court Green Lights Education Department Layoffs
Four ‘1-in-1,000-Year’ Storms Strike U.S. in Seven Days
John MacArthur, Influential Pastor and Theologian, Dies at 86
9 Killed As Fire Hits Massachusetts Care Home; Dozens Injured
Pakistan Sentences Muslim To Death For Killing Christian (Worthy News In-Depth)
Pakistan Commission To Investigate Abuse Of Blasphemy Laws(Worthy News In-Depth)
Supreme Court Green Lights Education Department Layoffs
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.

Worthy Christian News